Xylazine bill protects DVMs' access to sedative, AVMA saysJuly 21, 2023Language within the SUPPORT Act will schedule xylazine as a Schedule III drug, but allow continued use of the FDA-approved animal drug by veterinarians
SPONSORED CONTENTLife Gets Busy, Stay ON POINT With Cytopoint®Simplify your approach to allergic pruritus with Cytopoint. Help maintain control of allergic itch when schedules get hectic for both veterinarians and pet owners alike. + Learn more
